OVB
- Product code
- OVB
- Device name
- Hydrogel Spacer
- Device class
- Class 2
- 21 CFR
- 21 CFR 892.5725
- Medical specialty
- Radiology
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 1
- Summaries archived here
- 1 (direct download)
- 510(k) clearances (all years, FDA)
- 7 (all years; only the last 3 years are listed here)
FDA classification definition
The perirectal spacer is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of the perirectal spacer to reduce the radiation dose delivered to the anterior rectum. The perirectal spacer is composed of biodegradable material and maintains space for the entire course of prostate radiotherapy treatment and is completely absorbed by the patients body over time.
510(k) clearances, last 3 years (1)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K260119 | 2026-02-10 | Boston Scientific Corporation | SpaceOAR Vue System (SV-2101) |
Official FDA classification page: OVB
Classification and pathway per current FDA publications. Data from openFDA (CC0).